Mediplantex National Pharmaceutical JSC (HNX:MED)
18,400
0.00 (0.00%)
At close: May 13, 2026
HNX:MED Market Cap
HNX:MED has a market cap or net worth of 228.34 billion as of October 13, 2026. It is the 42,351st most valuable company in the world and the 501st biggest in Vietnam. Its market cap has decreased by 32.60% in one year.
Market Cap
228.34B
Enterprise Value
231.16B
Revenue
291.40B
Global Rank
Country Rank
#501 Vietnam
PE Ratio
9.51
ChartMarket Cap Chart
Since March 18, 2020, HNX:MED's market cap has decreased from 307.72B to 228.34B, a decrease of -25.80%. That is a compound annual growth rate of -4.73%.
| Date | Market Cap | % Change |
|---|---|---|
| May 13, 2026 | 228.34B | -21.70% |
| Dec 31, 2025 | 291.64B | -12.96% |
| Dec 27, 2023 | 335.07B | 28.57% |
| Dec 26, 2022 | 260.61B | 38.79% |
| Dec 31, 2021 | 187.77B | -23.33% |
| Dec 24, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 18, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Central Pharmaceutical Joint Stock Company No3 | 1.29T |
| Pharmedic Pharmaceutical Medicinal JSC | 1.19T |
| Vidipha Central Pharmaceutical JSC | 716.61B |
| Ben Tre Pharmaceutical JSC | 285.57B |
| Vimedimex Medi-Pharma JSC | 239.32B |
| Phong Phu Pharmaceutical JSC | 160.16B |
| American Vietnamese Biotech Incorporation | 157.33B |
| Tipharco Pharmaceutical JSC | 142.64B |